The effects observed with our studies suggest that CSE-induced activation of ERK1/2 and NF-κB signaling cascades in BMCs may be a main contributor to abnormal immune responses linked to the pathogenesis of CS. The gene discussed is NFKB1; the disease is Cowden syndrome 1.